Breast Cancer ICD-10 Code Reference Sheet. FEMALE. Right. C50.011. Malignant neoplasm of nipple and areola, right female breast. C50.111. Malignant neoplasm of central portion, right female breast. C50.211. Malignant neoplasm of upper-inner quadrant, right female breast.
C50.919 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Malignant neoplasm of unsp site of unspecified female breast. The 2021 edition of ICD-10-CM C50.919 became effective on October 1, 2020.
C50.912 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM C50.912 became effective on October 1, 2018. This is the American ICD-10-CM version of C50.912 - other international versions of ICD-10 C50.912 may differ. C50.912 is applicable to female patients.
C50.911 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM C50.911 became effective on October 1, 2020.
C50. 911 - Malignant neoplasm of unspecified site of right female breast | ICD-10-CM.
Example: Patient is diagnosed with lower inner-quadrant right breast cancer in May. The ICD-9-CM code is 174.3 malignant, primary (ICD-10: C50. 311).
Secondary malignant neoplasm of breast C79. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C79. 81 became effective on October 1, 2021.
C50. 912 - Malignant neoplasm of unspecified site of left female breast | ICD-10-CM.
ICD-10 code Z85. 3 for Personal history of malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code N63. 1 for Unspecified lump in the right breast is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80. 1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79. 51, C80.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
919 Malignant neoplasm of unspecified site of unspecified female breast.
D05. 1 - Intraductal carcinoma in situ of breast | ICD-10-CM.
Acquired absence of left breast and nipple The 2022 edition of ICD-10-CM Z90. 12 became effective on October 1, 2021.
A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast.
k. Code C80. 1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.
Acquired absence of left breast and nipple The 2022 edition of ICD-10-CM Z90. 12 became effective on October 1, 2021.
Breast Cancer Scenario: Should be coded as historical (Z85. 3) after the breast cancer has been excised or eradicated, there is no active treatment directed to the breast cancer and there is currently no evidence of disease or recurrence.
ICD-Code I10 is a billable ICD-10 code used for healthcare diagnosis reimbursement of Essential (Primary) Hypertension.